Fig. 3From: Comparison of PSA value at last follow-up of patients who underwent low-dose rate brachytherapy and intensity-modulated radiation therapy for prostate cancer a Biochemical recurrence-free rate of the LDR-BT group stratified by D’Amico risk classification using the definition of PSA ≥ 0.2 ng/mL. b Biochemical recurrence-free rate of the IMRT group stratified by D’Amico risk classification using the definition of PSA ≥ 0.2 ng/mLBack to article page